ATE523601T1 - Verfahren und zusammensetzungen zur vorhersage der reaktion auf warfarin - Google Patents

Verfahren und zusammensetzungen zur vorhersage der reaktion auf warfarin

Info

Publication number
ATE523601T1
ATE523601T1 AT05804256T AT05804256T ATE523601T1 AT E523601 T1 ATE523601 T1 AT E523601T1 AT 05804256 T AT05804256 T AT 05804256T AT 05804256 T AT05804256 T AT 05804256T AT E523601 T1 ATE523601 T1 AT E523601T1
Authority
AT
Austria
Prior art keywords
compositions
methods
warfarin
predicting response
present
Prior art date
Application number
AT05804256T
Other languages
English (en)
Inventor
Mark Rieder
Allan Rettie
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36181207&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE523601(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Washington filed Critical Univ Washington
Priority claimed from PCT/US2005/037058 external-priority patent/WO2006044686A2/en
Application granted granted Critical
Publication of ATE523601T1 publication Critical patent/ATE523601T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Stringed Musical Instruments (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT05804256T 2004-10-18 2005-10-17 Verfahren und zusammensetzungen zur vorhersage der reaktion auf warfarin ATE523601T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/967,879 US7445896B2 (en) 2004-10-18 2004-10-18 Methods and compositions for detecting VKORC1 single nucleotide polymorphisms
US11/141,288 US20060084081A1 (en) 2004-10-18 2005-05-31 Methods and compositions for predicting drug responses
PCT/US2005/037058 WO2006044686A2 (en) 2004-10-18 2005-10-17 Methods and compositions for predicting drug responses

Publications (1)

Publication Number Publication Date
ATE523601T1 true ATE523601T1 (de) 2011-09-15

Family

ID=36181207

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05804256T ATE523601T1 (de) 2004-10-18 2005-10-17 Verfahren und zusammensetzungen zur vorhersage der reaktion auf warfarin

Country Status (5)

Country Link
US (8) US7445896B2 (de)
AT (1) ATE523601T1 (de)
DK (1) DK1809767T3 (de)
ES (1) ES2373044T3 (de)
IL (1) IL182519A0 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004025157D1 (de) * 2003-09-23 2010-03-04 Univ North Carolina Zellen, die Vitamin-K-Reduktase und Vitamin-K-abhängiges Protein coexprimieren und deren Anwendung zur Verbesserung der Produktivität von diesem Vitamin-K-abhängigen Protein
WO2006012902A2 (en) * 2004-08-02 2006-02-09 Novozymes A/S Creation of diversity in polypeptides
ES2347167T3 (es) * 2004-12-21 2010-10-26 Academia Sinica Variantes geneticas de vkorc1 que predicen la sensibilidad a warfarina.
CA2601574C (en) 2005-03-15 2014-12-02 University Of North Carolina At Chapel Hill Methods and compositions for producing active vitamin k-dependent proteins
EP1987146A4 (de) * 2006-01-27 2009-08-19 Paragondx Llc Verfahren zur erzeugung von referenzkontrollen für pharmakogenomische tests
WO2007110869A2 (en) 2006-03-28 2007-10-04 Tel Hashomer Medical Research Infrastructure And Services Ltd. Methods and kits for determining predisposition to warfarin resistance
US8380539B2 (en) * 2006-05-09 2013-02-19 University Of Louisville Research Foundation, Inc. Personalized medicine management software
US20070298426A1 (en) * 2006-06-02 2007-12-27 Academia Sinica Warfarin dosage prediction
US20090216561A1 (en) * 2008-02-22 2009-08-27 Swedish Health Services Methods for management of anticoagulation therapy
US20100137426A1 (en) * 2008-05-01 2010-06-03 Paragon Method for generating reference controls for pharmacogenomic testing
WO2010048020A1 (en) * 2008-10-20 2010-04-29 Epitome Pharmaceuticals Limited Methods and systems for improved pharmaceutical intervention in coagulation control
US9631002B2 (en) 2010-12-21 2017-04-25 The University Of North Carolina At Chapel Hill Methods and compositions for producing active vitamin K-dependent proteins
US9417210B2 (en) 2011-09-30 2016-08-16 Pandora Genomics, LLC System, apparatus and method for evaluating samples or analytes using a point-of-care device
CN108570498B (zh) * 2018-05-25 2021-11-23 山东维真生物科技有限公司 用于检测人类cyp2c9和vkorc1基因多态性的引物探针组合物、试剂盒及应用
EP3935581A4 (de) 2019-03-04 2022-11-30 Iocurrents, Inc. Datenkompression und -kommunikation mit maschinenlernung

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4998617A (en) * 1986-09-15 1991-03-12 Laura Lupton Inc Facial cosmetic liquid make up kit
US5605798A (en) * 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
DE69433811T2 (de) * 1993-01-07 2005-06-23 Sequenom, Inc., San Diego Dns - sequenzierung durch massenspektronomie
US5593826A (en) * 1993-03-22 1997-01-14 Perkin-Elmer Corporation, Applied Biosystems, Inc. Enzymatic ligation of 3'amino-substituted oligonucleotides
WO1995034679A2 (en) 1994-06-16 1995-12-21 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Defects in drug metabolism
GB9415492D0 (en) * 1994-08-01 1994-09-21 Celltech Ltd Biological products
US6379670B1 (en) * 1994-11-18 2002-04-30 Neurocrine Biosciences, Inc. Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
DE602004025157D1 (de) 2003-09-23 2010-03-04 Univ North Carolina Zellen, die Vitamin-K-Reduktase und Vitamin-K-abhängiges Protein coexprimieren und deren Anwendung zur Verbesserung der Produktivität von diesem Vitamin-K-abhängigen Protein
DE602004026897D1 (de) 2003-10-14 2010-06-10 Baxter Healthcare Sa Vkorc1 (vitamin k epoxide recycling polypeptide), ein therapeutisches ziel für coumarin und deren derivate
WO2006044686A2 (en) 2004-10-18 2006-04-27 University Of Washington Methods and compositions for predicting drug responses
ES2347167T3 (es) * 2004-12-21 2010-10-26 Academia Sinica Variantes geneticas de vkorc1 que predicen la sensibilidad a warfarina.

Also Published As

Publication number Publication date
US8153366B2 (en) 2012-04-10
US20080050732A1 (en) 2008-02-28
US20110251272A1 (en) 2011-10-13
US20080057500A1 (en) 2008-03-06
US20080318219A1 (en) 2008-12-25
US20060084081A1 (en) 2006-04-20
US7888016B2 (en) 2011-02-15
DK1809767T3 (da) 2011-12-12
US7829282B2 (en) 2010-11-09
US7445896B2 (en) 2008-11-04
US9074257B2 (en) 2015-07-07
US20060084070A1 (en) 2006-04-20
US20140148505A1 (en) 2014-05-29
HK1105437A1 (en) 2008-02-15
US8614060B2 (en) 2013-12-24
IL182519A0 (en) 2007-09-20
ES2373044T3 (es) 2012-01-30
US20080050733A1 (en) 2008-02-28

Similar Documents

Publication Publication Date Title
IL182519A0 (en) Methods and compositions for predicting drug responses
WO2007146819A3 (en) Methods for identifying and using snp panels
Alagarasu et al. Association of promoter region polymorphisms of CD209 gene with clinical outcomes of dengue virus infection in Western India
TW200636075A (en) Detection of nucleic acid variation by cleavage-amplification method
ATE483825T1 (de) Zusammensetzungen für die identifizierung von adenoviren
DE602006015793D1 (de) Proteolipidmembran und lipidmembranen-biosensor
DK1831402T3 (da) Genetiske varianter af VKORC1 til forudsigelse af warfarin-følsomhed
WO2004101806A3 (en) Allele-specific expression patterns
WO2008132763A3 (en) Genetic variants useful for risk assessment of coronary artery disease and myocardial infarction
WO2008076856A3 (en) Reagents and methods for detecting cyp2d6 polymorphisms
WO2005083127A3 (en) Genetic polymorphisms associated with stroke, methods of detection and uses thereof
WO2012061502A3 (en) Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
WO2009032316A3 (en) Genetic polymorphisms associated with rheumatoid arhritis, methods of detection and uses thereof
BRPI0809143B8 (pt) método in vitro para identificar um indivíduo que apresente um risco alterado para desenvolver doença cardíaca coronária (chd) ou aneurisma/dissecção
ATE446385T1 (de) Polymorphismen im nod2/card15 gen
ATE386823T1 (de) Marker-unterstützte rinderauswahl für verbesserte milchzusammensetzung
WO2006044686A3 (en) Methods and compositions for predicting drug responses
WO2007050794A3 (en) The il-1 gene cluster and associated inflammatory polymorphisms and haplotypes
WO2008048902A8 (en) Methods of using single nucleotide polymorphisms in the il23r gene to predict or diagnose inflammatory bowel disease
WO2007120843A3 (en) Single nucleotide polymorphism detection from unamplified genomic dna
WO2003064600A3 (en) The il-1 gene cluster and associated inflammatory polymorphisms and haplotypes
DK1613772T3 (da) Fremgangsmåde til bestemmelse af tilstanden af jord
ATE479776T1 (de) Polymorphismen des frzb gens und deren zusammenhang mit osteoporose
BRPI0418722A (pt) ensaios baseados em ácidos nucléicos para identificação de polimorfismos do receptor fc
ATE431431T1 (de) Diagnose von uniparentaler disomie anhand von singel-nukleotid-polymorphismen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1809767

Country of ref document: EP